MedPath
FDA Approval

Bromfenac

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 17, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Bromfenac(1.035 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Bromfenac

Product Details

NDC Product Code
54868-6343
Application Number
ANDA201211
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
April 17, 2012
Benzalkonium chlorideInactive
Code: F5UM2KM3W7Class: IACTQuantity: 0.05 mg in 1 mL
povidoneInactive
Code: FZ989GH94EClass: IACTQuantity: 20 mg in 1 mL
sodium borateInactive
Code: 91MBZ8H3QOClass: IACTQuantity: 11 mg in 1 mL
waterInactive
Code: 059QF0KO0RClass: IACT
sodium sulfiteInactive
Code: VTK01UQK3GClass: IACTQuantity: 2 mg in 1 mL
Boric acidInactive
Code: R57ZHV85D4Class: IACTQuantity: 11 mg in 1 mL
BromfenacActive
Code: 8ECV571Y37Class: ACTIBQuantity: 1.035 mg in 1 mL
edetate disodiumInactive
Code: 7FLD91C86KClass: IACTQuantity: 0.2 mg in 1 mL
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACTQuantity: 1.5 mg in 1 mL
sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath